首页> 外文期刊>Applied Surface Science >New insights in poly(vinylidene fluoride) (PVDF) membrane hemocompatibility: Synergistic effect of PVDF-g-(acryloyl morpholine) and PVDF-g-(poly(acrylic acid)-argatroban) copolymers
【24h】

New insights in poly(vinylidene fluoride) (PVDF) membrane hemocompatibility: Synergistic effect of PVDF-g-(acryloyl morpholine) and PVDF-g-(poly(acrylic acid)-argatroban) copolymers

机译:聚偏二氟乙烯(PVDF)膜血液相容性的新见解:PVDF-g-(丙烯酰基吗啉)和PVDF-g-(聚(丙烯酸)-阿加曲班)共聚物的协同效应

获取原文
获取原文并翻译 | 示例

摘要

Hydrophilic and hemocompatible surface design is vital for poly(vinylidene fluoride) (PVDF) membranes in biological application especially for hemodialysis. In this work, the influence and synergistic effect of PVDF-g-(acryloyl morpholine) (PVDF-g-ACMO) and PVDF-g-(poly(acrylic acid)-argatroban) (PVDF-g-(PAA-AG)) copolymers blending modification on structure and properties of PVDF membrane were investigated. The membranes were prepared through immersion phase transition method. The copolymer structure was characterized by FT-IR and H-1 NMR. Modified membrane surfaces obtained were characterized by XPS. The blending modified PVDF hollow fiber membranes were confirmed to have excellent hydrophilicity, good hemocompatibility properties (protein adsorption, platelets/ red blood cells adhesion, plasma coagulation), good permeability and anti-protein fouling performance. The hydrophilic and anti-hemolytic properties were significantly improved with the weight percentage of PVDF-g-ACMO copolymer, and PVDF-g-(PAA-AG) copolymer endow the anti-coagulation of modified membranes. And when the blend ratio was up to 1:3, the blend membranes show the longest clotting time (APTT 114.15 s and PT 25.65 s). This work provides a new modification method to improve the hemocompatibility for PVDF membranes in potential biological applications.
机译:亲水和血液相容性表面设计对于生物应用中的聚偏二氟乙烯(PVDF)膜(尤其是血液透析)至关重要。在这项工作中,PVDF-g-(丙烯酰基吗啉)(PVDF-g-ACMO)和PVDF-g-(聚(丙烯酸)-argatroban)(PVDF-g-(PAA-AG))的影响和协同效应研究了共聚物共混改性对PVDF膜结构和性能的影响。膜是通过浸没相变法制备的。通过FT-IR和H-1 NMR表征共聚物结构。通过XPS表征获得的改性膜表面。证实该共混改性的PVDF中空纤维膜具有优异的亲水性,良好的血液相容性(蛋白质吸附,血小板/红细胞粘附,血浆凝结),良好的渗透性和抗蛋白质结垢性能。 PVDF-g-ACMO共聚物的重量百分比显着提高了亲水性和抗溶血性,而PVDF-g-(PAA-AG)共聚物则赋予了改性膜抗凝性。当混合比达到1:3时,混合膜显示出最长的凝结时间(APTT 114.15 s和PT 25.65 s)。这项工作提供了一种新的修饰方法,以提高潜在生物应用中PVDF膜的血液相容性。

著录项

  • 来源
    《Applied Surface Science》 |2018年第1期|170-178|共9页
  • 作者单位

    Tianjin Polytech Univ, Sch Mat Sci & Engn, State Key Lab Separat Membranes & Membrane Proc, Tianjin 300387, Peoples R China;

    Tianjin Polytech Univ, Sch Mat Sci & Engn, State Key Lab Separat Membranes & Membrane Proc, Tianjin 300387, Peoples R China;

    Tianjin Polytech Univ, Sch Mat Sci & Engn, State Key Lab Separat Membranes & Membrane Proc, Tianjin 300387, Peoples R China;

    Tianjin Polytech Univ, Sch Mat Sci & Engn, State Key Lab Separat Membranes & Membrane Proc, Tianjin 300387, Peoples R China;

    Tianjin Polytech Univ, Sch Mat Sci & Engn, State Key Lab Separat Membranes & Membrane Proc, Tianjin 300387, Peoples R China;

    Tianjin Polytech Univ, Sch Mat Sci & Engn, State Key Lab Separat Membranes & Membrane Proc, Tianjin 300387, Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    PVDF membrane; Synergistic Effect; Acryloyl morpholine; Argatroban;

    机译:PVDF膜;协同效应;酰基吗啉;Argatroban;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号